Results 161 to 170 of about 6,257,121 (349)

A Comparative Analysis on Ethical Benchmarking in Large Language Models [PDF]

arXiv
This work contributes to the field of Machine Ethics (ME) benchmarking, which develops tests to assess whether intelligent systems accurately represent human values and act accordingly. We identify three major issues with current ME benchmarks: limited ecological validity due to unrealistic ethical dilemmas, unstructured question generation without ...
arxiv  

Ethics for the Medical Appliance Dealer

, 1953
Sakunosuke Ichikawa
openalex   +2 more sources

Two Texts on Medical Ethics Ethics in Medicine: Historical Perspectives and Contemporary Concerns Stanley Joel Reiser Arthur J. Dyck William J. Curran Case Studies in Medical Ethics Robert M. Veatch [PDF]

, 1978
Howard Brody
openalex   +1 more source

Medical Ethics [PDF]

CA: A Cancer Journal for Clinicians, 1986
H B, Haley, B A, Brody
openaire   +2 more sources

Exploration of heterogeneity and recurrence signatures in hepatocellular carcinoma

Molecular Oncology, EarlyView.
This study leveraged public datasets and integrative bioinformatic analysis to dissect malignant cell heterogeneity between relapsed and primary HCC, focusing on intercellular communication, differentiation status, metabolic activity, and transcriptomic profiles.
Wen‐Jing Wu, Jianchao Wang, Fuqing Chen, Xuefeng Wang, Bin Lan, Ruyi Fu, Hong Wen, Fangfang Chen, Wei Hong, Tian‐Yu Tang, Ying He, Gang Chen, Jianyin Zhou, Hai‐Long Piao, Di Chen, Shu‐Yong Lin   +15 more
wiley   +1 more source

Points from Letters: Abortions and Legal and Medical Ethics [PDF]

, 1971
J. Slome
openalex   +1 more source

The atypical KRASQ22K mutation directs TGF‐β response towards partial epithelial‐to‐mesenchymal transition in patient‐derived colorectal cancer tumoroids

Molecular Oncology, EarlyView.
TGF‐β has a complex role in cancer, exhibiting both tumor‐suppressive and tumor‐promoting properties. Using a series of differentiated tumoroids, derived from different stages and mutational background of colorectal cancer patients, we replicate this duality of TGF‐β in vitro. Notably, the atypical but highly aggressive KRASQ22K mutation rendered early‐
Theresia Mair, Philip König, Milena Mijović, Jessica Kalla, Anil Baskan, Loan Tran, Kristina Draganić, Pedro Morata Saldaña, Carlos Uziel Pérez Malla, Janette Pfneissl, Andreas Tiefenbacher, Julijan Kabiljo, Velina S. Atanasova, Lisa Wozelka‐Oltjan, Leonhard Müllauer, Michael Bergmann, Raheleh Sheibani‐Tezerji, Gerda Egger   +17 more
wiley   +1 more source

New horizons in medical ethics. Who is the patient's friend? [PDF]

, 1973
R. Klein, David A. Pyke, Anthony M. Smith   +2 more
openalex   +1 more source

A large‐scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression‐free survival

Molecular Oncology, EarlyView.
There is an unmet need in metastatic breast cancer patients to monitor therapy response in real time. In this study, we show how a noninvasive and affordable strategy based on sequencing of plasma samples with longitudinal tracking of tumour fraction paired with a statistical model provides valuable information on treatment response in advance of the ...
Emma J. Beddowes, Mario Ortega Duran, Solon Karapanagiotis, Alistair Martin, Meiling Gao, Riccardo Masina, Ramona Woitek, James Tanner, Fleur Tippin, Justine Kane, Jonathan Lay, Anja Brouwer, Stephen‐John Sammut, Suet‐Feung Chin, Davina Gale, Dana W. Y. Tsui, Sarah‐Jane Dawson, Nitzan Rosenfeld, Maurizio Callari, Oscar M. Rueda, Carlos Caldas   +20 more
wiley   +1 more source

TRIAGE: Ethical Benchmarking of AI Models Through Mass Casualty Simulations [PDF]

arXiv
We present the TRIAGE Benchmark, a novel machine ethics (ME) benchmark that tests LLMs' ability to make ethical decisions during mass casualty incidents. It uses real-world ethical dilemmas with clear solutions designed by medical professionals, offering a more realistic alternative to annotation-based benchmarks.
arxiv